Published in Am J Med on April 01, 1994
Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob Agents Chemother (1996) 1.51
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev (2012) 1.22
Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center. Haematologica (2016) 0.77
Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med (1986) 3.89
Atypical biogroups of Escherichia coli found in clinical specimens and description of Escherichia hermannii sp. nov. J Clin Microbiol (1982) 3.84
Rapid radioimmunoassay diagnosis of Legionnaires' disease: detection and partial characterization of urinary antigen. Ann Intern Med (1981) 2.60
Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia. J Clin Microbiol (1993) 2.49
Diagnosis and etiology of nongonococcal urethritis. J Infect Dis (1978) 2.40
Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen. J Clin Microbiol (1997) 2.37
Rapid diagnosis of Legionnaires' disease by latex agglutination. Am Rev Respir Dis (1983) 2.35
Rapid diagnosis of Legionnaires' disease by urinary antigen detection. Comparison of ELISA and radioimmunoassay. Am J Med (1982) 2.30
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates. Antimicrob Agents Chemother (1991) 2.26
Automated reading of MIC microdilution trays containing fluorogenic enzyme substrates with the Sensititre Autoreader. J Clin Microbiol (1985) 2.20
Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J Clin Microbiol (1992) 2.18
Meningoencephalitis and compartmentalization of the cerebral ventricles caused by Enterobacter sakazakii. J Clin Microbiol (1981) 2.01
Onset and duration of urinary antigen excretion in Legionnaires disease. J Clin Microbiol (1984) 1.98
Use of ethanol for selective isolation of sporeforming microorganisms. Appl Environ Microbiol (1978) 1.86
Volume of blood submitted for culture from neonates. J Clin Microbiol (1986) 1.77
Multicenter comparison of the high volume (10 ml) NR BACTEC PLUS system and the standard (5 ml) NR BACTEC system. Diagn Microbiol Infect Dis (1991) 1.73
Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group. Clin Infect Dis (2000) 1.73
Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. Clin Infect Dis (2000) 1.72
Human immune response to iron-repressible outer membrane proteins of Neisseria meningitidis. Infect Immun (1986) 1.70
Infection and diabetes mellitus. Diabetes Care (1980) 1.64
Evaluation of the new RapID-ANA II system for the identification of clinical anaerobic isolates. J Clin Microbiol (1991) 1.60
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits. J Antimicrob Chemother (1996) 1.59
Anaerobic flora of the normal human conjunctival sac. Arch Ophthalmol (1978) 1.52
Solid-phase radioimmunoassay for immunoglobulin G Staphylococcus aureus antibody in serious staphylococcal infection. Ann Intern Med (1978) 1.51
Diabetic foot infections. Bacteriologic analysis. Arch Intern Med (1986) 1.51
Multicenter in vitro evaluation of SM-7338, a new carbapenem. Antimicrob Agents Chemother (1989) 1.50
Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination. J Clin Microbiol (1996) 1.49
Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med (2000) 1.49
Neisserial antigen H.8 is immunogenic in patients with disseminated gonococcal and meningococcal infections. J Infect Dis (1985) 1.43
The microbiology and therapy of acute pelvic inflammatory disease in hospitalized patients. Am J Obstet Gynecol (1980) 1.42
The diabetic foot. Soft tissue and bone infection. Infect Dis Clin North Am (1990) 1.40
Ureolytic Escherichia coli of human origin: serological, epidemiological, and genetic analysis. J Clin Microbiol (1979) 1.35
Opsonization of staphylococci by normal human sera: the role of antibody and heat-labile factors. J Lab Clin Med (1974) 1.32
Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin. J Antimicrob Chemother (1993) 1.32
Cross-reactive urinary antigens among patients infected with Legionella pneumophila serogroups 1 and 4 and the Leiden 1 strain. J Infect Dis (1985) 1.32
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 1.32
Clostridium clostridioforme: a mixture of three clinically important species. Eur J Clin Microbiol Infect Dis (2005) 1.29
Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure. Diagn Microbiol Infect Dis (1987) 1.29
Fungal infections in AIDS patients. J Med Vet Mycol (1992) 1.27
Rapid and effective method for preparation of fecal specimens for PCR assays. J Clin Microbiol (1997) 1.26
Serratia marcescens infection of the urinary tract: a nosocomial infection. J Urol (1969) 1.25
Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med (1982) 1.24
A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med (1981) 1.24
Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unliganded form and in complex with FK506 and rapamycin. Acta Crystallogr D Biol Crystallogr (1995) 1.22
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis (1991) 1.21
Histoplasmosis in the acquired immune deficiency syndrome. Am J Med (1985) 1.20
Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol (1989) 1.19
Improved detection of Histoplasma antigenemia following dissociation of immune complexes. Clin Vaccine Immunol (2009) 1.18
Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)- 2-alkylisoxazolidine derivatives. J Med Chem (1988) 1.18
Comparison of sandwich solid-phase radioimmunoassay and two enzyme-linked immunosorbent assays for detection of Histoplasma capsulatum polysaccharide antigen. J Infect Dis (1989) 1.17
Staphylococcal heat-stable opsonins. J Lab Clin Med (1974) 1.17
Histoplasmosis in renal allograft recipients. Two large urban outbreaks. Arch Intern Med (1983) 1.17
Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria. J Clin Microbiol (1989) 1.16
Opportunistic Scopulariopsis pneumonia in an immunocompromised host. South Med J (1984) 1.16
Isolation of a novel transposon which carries the Escherichia coli enterotoxin STII gene. J Bacteriol (1985) 1.16
Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol (2008) 1.16
Rapid diagnosis of pneumonia due to Legionella pneumophila serogroup 1. J Infect Dis (1982) 1.15
Distribution of the two mating types among Histoplasma capsulatum isolates obtained from an urban histoplasmosis outbreak. Sabouraudia (1984) 1.14
Bacteremia with upper gastrointestinal endoscopy. Ann Intern Med (1975) 1.13
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates. J Antimicrob Chemother (1993) 1.13
Immunodiagnosis of invasive fungal infection. J Med Vet Mycol (1992) 1.10
Methicillin-resistant Staphylococcus aureus: interstate spread of nosocomial infections with emergence of gentamicin-methicillin resistant strains. Infect Control (1982) 1.10
Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards. J Clin Microbiol (1989) 1.10
Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model. Antimicrob Agents Chemother (2000) 1.10
Diagnosis of acute pulmonary histoplasmosis by antigen detection. Clin Infect Dis (2009) 1.09
Meningitis with beta-lactam-resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture. Pediatr Infect Dis J (1993) 1.09
Recurrent urban histoplasmosis, Indianapolis, Indiana, 1980-1981. Am J Epidemiol (1983) 1.07
Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients. Am J Med (1998) 1.07
Prevalence of fluoroquinolone-resistant bacterial isolates in four medical centers during the first quarter of 1990. Eur J Clin Microbiol Infect Dis (1990) 1.07
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains. Diagn Microbiol Infect Dis (1990) 1.06
Chronic infection and reactivation in a pulmonary challenge model of histoplasmosis. J Infect Dis (2001) 1.06
Rapid diagnosis of Pseudomonas aeruginosa urinary tract infections by radioimmunoassay. J Clin Microbiol (1979) 1.04
Rapid MIC testing with the sensititre autoreader. J Clin Microbiol (1988) 1.04
Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactams. J Clin Microbiol (1992) 1.04
Increase in antibiotic resistance among isolates of Salmonella in the United States, 1967-1975. J Infect Dis (1980) 1.01
Bacteriological studies in a patient with antibiotic-associated pseudomembranous colitis. Gastroenterology (1977) 1.01
Thermodissociation of staphylococcal immune complexes and detection of staphylococcal antigen in serum from patients with Staphylococcus aureus bacteremia. J Clin Microbiol (1980) 1.00
Prevalence of foot complaints in the elderly. J Am Podiatr Med Assoc (1987) 1.00
Host defences and the vaginal mucosa. A re-evaluation. Scand J Urol Nephrol Suppl (1984) 1.00
Local immunity in lung-associated lymph nodes in a murine model of pulmonary histoplasmosis. Infect Immun (1993) 1.00
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression. AIDS (2001) 0.99
Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin. J Clin Microbiol (1992) 0.98
Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis (2001) 0.98
Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis. J Infect Dis (2000) 0.98
Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice. Am J Transplant (2012) 0.98
Solid-phase radioimmunoassay for detection of staphylococcal antigen in serum of rabbits with endocraditis due to Staphylococcus aureus. J Infect Dis (1978) 0.97
Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis (2002) 0.97
Disseminated histoplasmosis in AIDS: findings on chest radiographs. AJR Am J Roentgenol (1993) 0.97
Clinical, pathogenetic, and laboratory features of Capnocytophaga infections. Am J Clin Pathol (1986) 0.96
Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses study group. Antimicrob Agents Chemother (2000) 0.96
Immunoglobulin M and G histoplasmal antibody response in histoplasmosis. Am Rev Respir Dis (1983) 0.96
Evaluation of a commercial latex test for Clostridium difficile for reactivity with C. difficile and cross-reactions with other bacteria. J Clin Microbiol (1988) 0.95
Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin Vaccine Immunol (2008) 0.95
Multicenter, comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea. Sex Transm Dis (1989) 0.95
The temperature optimum of the intestinal flora of the rat. Can J Microbiol (1968) 0.95
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years. Diagn Microbiol Infect Dis (1995) 0.95